Takeda Agrees to Pay $2.4 Billion to Settle Suits Over Cancer Risk of Actos

New York TimesTakeda Agrees to Pay $2.4 Billion to Settle Suits Over Cancer Risk of ActosNew York TimesTakeda Pharmaceutical has agreed to pay $2.4 billion to settle thousands of lawsuits from patients and their family members who said that the company's diabetes drug Actos caused bladder cancer, it announced on Tuesday. Takeda, a Japanese company, ...Takeda to pay $2.7bn to settle Actos cancer claimsFinancial TimesTakeda Agrees to Pay $2.4 Billion to Settle Actos Bladder Cancer LawsuitsLegal ExaminerJapan's Takeda Agrees To $2.4B Settlement In Diabetes Drug Actos Lawsuit ...International Business TimesPMLiVEall 112 news articles »

Share this post